CONFERENCE COMMITTEE REP. NO. 52

Honolulu, Hawaii

, 2023

RE: H.B. No. 218

H.D. 2

S.D. 2

C.D. 1

Honorable Scott K. Saiki

Speaker, House of Representatives

Thirty-Second State Legislature

Regular Session of 2023

State of Hawaii

Honorable Ronald D. Kouchi

President of the Senate

Thirty-Second State Legislature

Regular Session of 2023

State of Hawaii

Sirs:

Your Committee on Conference on the disagreeing vote of the House of Representatives to the amendments proposed by the Senate in H.B. No. 218, H.D. 2, S.D. 2, entitled:

"A BILL FOR AN ACT RELATING TO PRESCRIPTION DRUGS,"

having met, and after full and free discussion, has agreed to recommend and does recommend to the respective Houses the final passage of this bill in an amended form.

The purpose of this measure is to require:

(1) Dispensing pharmacies to provide accessible prescription drug label information to individuals who have difficulty seeing or reading labels on prescription drug containers;

(2) Dispensing pharmacies to make sustained, periodic, and reasonable efforts to inform the public that prescription drug label information is available in alternative accessible formats; and

(3) The Board of Pharmacy to adopt rules by December 31, 2024, to carry out the purposes of this measure.

Your Committee on Conference has amended this measure by:

(1) Changing the effective date to July 1, 2023; and

(2) Making technical, nonsubstantive amendments for the purposes of clarity, consistency, and style.

As affirmed by the record of votes of the managers of your Committee on Conference that is attached to this report, your Committee on Conference is in accord with the intent and purpose of H.B. No. 218, H.D. 2, S.D. 2, as amended herein, and recommends that it pass Final Reading in the form attached hereto as H.B. No. 218, H.D. 2, S.D. 2, C.D. 1.

Respectfully submitted on behalf of the managers:

ON THE PART OF THE SENATE

ON THE PART OF THE HOUSE

____________________________ MAILE S.L. SHIMABUKURO Chair	____________________________ DELLA AU BELATTI Co-Chair
____________________________ JARRETT KEOHOKALOLE Co-Chair	____________________________ MARK M. NAKASHIMA Co-Chair